Protein phosphatases and Alzheimer's Disease

Progress in Molecular Biology and Translational Science

Volumn 106, Issue , 2012, Pages 343-379

  Braithwaite, Steven P ^a   Stock, Jeffry B ^b   Lombroso, Paul J ^c   Nairn, Angus C ^d  

^a Signum Biosciences   (United States)

^b PRINCETON UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcineurin; Dephosphorylation; Phosphorylation; PP1; PP2A; PP2B; PP5; Protein phosphatase; STEP

Indexed keywords

EID: 84857227455     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-396456-4.00012-2     Document Type: Chapter

References (251)

1. R.J. Castellani, R.K. Rolston, and M.A. Smith Alzheimer disease Dis Mon 56 2010 484 546
2. A. Probst, D. Langui, and J. Ulrich Alzheimer's disease: a description of the structural lesions Brain Pathol 1 1991 229 239
3. C. Haass, and D.J. Selkoe Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide Nat Rev Mol Cell Biol 8 2007 101 112 (Pubitemid 46432529)
4. A. Goate, M.C. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, and L. Fidani Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease Nature 349 1991 704 706 (Pubitemid 21912142)
5. P. Pastor, and A.M. Goate Molecular genetics of Alzheimer's disease Curr Psychiatry Rep 6 2004 125 133 (Pubitemid 38899262)
6. L. Crews, E. Rockenstein, and E. Masliah APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis Brain Struct Funct 214 2010 111 126
7. M.S. Wolfe Structure, mechanism and inhibition of gamma-secretase and presenilin-like proteases Biol Chem 391 2010 839 847
8. D.V. Venkitaramani, J. Chin, W.J. Netzer, G.K. Gouras, S. Lesne, and R. Malinow Beta-amyloid modulation of synaptic transmission and plasticity J Neurosci 27 2007 11832 11837 (Pubitemid 350072092)
9. J.J. Palop, and L. Mucke Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks Nat Neurosci 13 2010 812 818
10. T. Suzuki, M. Oishi, D.R. Marshak, A.J. Czernik, A.C. Nairn, and P. Greengard Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein EMBO J 13 1994 1114 1122 (Pubitemid 24074718)
11. T. Suzuki, K. Ando, T. Isohara, M. Oishi, G.S. Lim, and Y. Satoh Phosphorylation of Alzheimer beta-amyloid precursor-like proteins Biochemistry 36 1997 4643 4649 (Pubitemid 27180314)
12. M. Oishi, A.C. Nairn, A.J. Czernik, G.S. Lim, T. Isohara, and S.E. Gandy The cytoplasmic domain of Alzheimer's amyloid precursor protein is phosphorylated at Thr654, Ser655, and Thr668 in adult rat brain and cultured cells Mol Med 3 1997 111 123 (Pubitemid 27229839)
13. T. Isohara, A. Horiuchi, T. Watanabe, K. Ando, A.J. Czernik, and I. Uno Phosphorylation of the cytoplasmic domain of Alzheimer's beta-amyloid precursor protein at Ser655 by a novel protein kinase Biochem Biophys Res Commun 258 1999 300 305 (Pubitemid 29287046)
14. K. Iijima, K. Ando, S. Takeda, Y. Satoh, T. Seki, and S. Itohara Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5 J Neurochem 75 2000 1085 1091 (Pubitemid 30660497)
15. T. Suzuki, K. Ando, K. Iijima, S. Oguchi, and S. Takeda Phosphorylation of amyloid precursor protein (APP) family proteins Methods Mol Med 32 2000 271 282
16. Y. Sano, T. Nakaya, S. Pedrini, S. Takeda, K. Iijima-Ando, and K. Iijima Physiological mouse brain Abeta levels are not related to the phosphorylation state of threonine-668 of Alzheimer's APP PLoS One 1 2006 e51
17. E. da Cruz, E.F. Silva, E. da Cruz, and O.A. Silva Protein phosphorylation and APP metabolism Neurochem Res 28 2003 1553 1561 (Pubitemid 37193538)
18. K. Ando, K.I. Iijima, J.I. Elliott, Y. Kirino, and T. Suzuki Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta-amyloid J Biol Chem 276 2001 40353 40361
19. M. Seeger, C. Nordstedt, S. Petanceska, D.M. Kovacs, G.K. Gouras, and S. Hahne Evidence for phosphorylation and oligomeric assembly of presenilin 1 Proc Natl Acad Sci USA 94 1997 5090 5094 (Pubitemid 27214741)
20. J. Walter, A. Schindzielorz, J. Grunberg, and C. Haass Phosphorylation of presenilin-2 regulates its cleavage by caspases and retards progression of apoptosis Proc Natl Acad Sci USA 96 1999 1391 1396 (Pubitemid 29098461)
21. R. Fluhrer, A. Friedlein, C. Haass, and J. Walter Phosphorylation of presenilin 1 at the caspase recognition site regulates its proteolytic processing and the progression of apoptosis J Biol Chem 279 2004 1585 1593 (Pubitemid 38084422)
22. L. Pastorino, A.F. Ikin, A.C. Nairn, A. Pursnani, and J.D. Buxbaum The carboxyl-terminus of BACE contains a sorting signal that regulates BACE trafficking but not the formation of total A(beta) Mol Cell Neurosci 19 2002 175 185 (Pubitemid 34211898)
23. C.A. von Arnim, M.M. Tangredi, I.D. Peltan, B.M. Lee, M.C. Irizarry, and A. Kinoshita Demonstration of BACE (beta-secretase) phosphorylation and its interaction with GGA1 in cells by fluorescence-lifetime imaging microscopy J Cell Sci 117 2004 5437 5445 (Pubitemid 39562504)
24. V.M. Lee, M. Goedert, and J.Q. Trojanowski Neurodegenerative tauopathies Annu Rev Neurosci 24 2001 1121 1159 (Pubitemid 32695256)
25. S. Wray, M. Saxton, B.H. Anderton, and D.P. Hanger Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats J Neurochem 105 2008 2343 2352 (Pubitemid 351782262)
26. D.P. Hanger, B.H. Anderton, and W. Noble Tau phosphorylation: the therapeutic challenge for neurodegenerative disease Trends Mol Med 15 2009 112 119
27. S.H. Chung Aberrant phosphorylation in the pathogenesis of Alzheimer's disease BMB Rep 42 2009 467 474
28. F. Liu, I. Grundke-Iqbal, K. Iqbal, and C.X. Gong Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation Eur J Neurosci 22 2005 1942 1950 (Pubitemid 41579384)
29. A. Rahman, I. Grundke-Iqbal, and K. Iqbal Phosphothreonine-212 of Alzheimer abnormally hyperphosphorylated tau is a preferred substrate of protein phosphatase-1 Neurochem Res 30 2005 277 287 (Pubitemid 40569212)
30. J.Z. Wang, I. Grundke-Iqbal, and K. Iqbal Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration Eur J Neurosci 25 2007 59 68 (Pubitemid 46098893)
31. W. Qian, J. Shi, X. Yin, K. Iqbal, I. Grundke-Iqbal, and C.X. Gong PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta J Alzheimers Dis 19 2010 1221 1229
32. A. Rahman, I. Grundke-Iqbal, and K. Iqbal PP2B isolated from human brain preferentially dephosphorylates Ser-262 and Ser-396 of the Alzheimer disease abnormally hyperphosphorylated tau J Neural Transm 113 2006 219 230 (Pubitemid 43121757)
33. C.X. Gong, F. Liu, G. Wu, S. Rossie, J. Wegiel, and L. Li Dephosphorylation of microtubule-associated protein tau by protein phosphatase 5 J Neurochem 88 2004 298 310 (Pubitemid 38084546)
34. F. Liu, K. Iqbal, I. Grundke-Iqbal, S. Rossie, and C.X. Gong Dephosphorylation of tau by protein phosphatase 5: impairment in Alzheimer's disease J Biol Chem 280 2005 1790 1796
35. T.D. Garver, R.L. Kincaid, R.A. Conn, and M.L. Billingsley Reduction of calcineurin activity in brain by antisense oligonucleotides leads to persistent phosphorylation of tau protein at Thr181 and Thr231 Mol Pharmacol 55 1999 632 641 (Pubitemid 29165427)
36. D.Y. Yu, J. Luo, F. Bu, G.J. Song, L.Q. Zhang, and Q. Wei Inhibition of calcineurin by infusion of CsA causes hyperphosphorylation of tau and is accompanied by abnormal behavior in mice Biol Chem 387 2006 977 983 (Pubitemid 44100244)
37. J. Luo, J. Ma, D.Y. Yu, F. Bu, W. Zhang, and L.H. Tu Infusion of FK506, a specific inhibitor of calcineurin, induces potent tau hyperphosphorylation in mouse brain Brain Res Bull 76 2008 464 468
38. V. Janssens, and J. Goris Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling Biochem J 353 2001 417 439 (Pubitemid 32158309)
39. S. Strack, J.A. Zaucha, F.F. Ebner, R.J. Colbran, and B.E. Wadzinski Brain protein phosphatase 2A: developmental regulation and distinct cellular and subcellular localization by B subunits J Comp Neurol 392 1998 515 527 (Pubitemid 28152405)
40. A. Saraf, D.M. Virshup, and S. Strack Differential expression of the B'beta regulatory subunit of protein phosphatase 2A modulates tyrosine hydroxylase phosphorylation and catecholamine synthesis J Biol Chem 282 2007 573 580 (Pubitemid 47076614)
41. M.J. Van Kanegan, and S. Strack The protein phosphatase 2A regulatory subunits B'beta and B'delta mediate sustained TrkA neurotrophin receptor autophosphorylation and neuronal differentiation Mol Cell Biol 29 2009 662 674
42. S.I. Walaas, H.C. Hemmings Jr., P. Greengard, and A.C. Nairn Beyond the dopamine receptor: regulation and roles of serine/threonine protein phosphatases Front Neuroanat 5 2011 50
43. T. Hunter The age of crosstalk: phosphorylation, ubiquitination, and beyond Mol Cell 28 2007 730 738 (Pubitemid 350217067)
44. C. Choudhary, and M. Mann Decoding signalling networks by mass spectrometry-based proteomics Nat Rev Mol Cell Biol 11 2010 427 439
45. S. Zolnierowicz Type 2A protein phosphatase, the complex regulator of numerous signaling pathways Biochem Pharmacol 60 2000 1225 1235
46. J. Lee, and J. Stock Protein phosphatase 2A catalytic subunit is methyl-esterified at its carboxyl terminus by a novel methyltransferase J Biol Chem 268 1993 19192 19195 (Pubitemid 23270686)
47. H. Xie, and S. Clarke An enzymatic activity in bovine brain that catalyzes the reversal of the C-terminal methyl esterification of protein phosphatase 2A Biochem Biophys Res Commun 203 1994 1710 1715 (Pubitemid 24321561)
48. T. Tolstykh, J. Lee, S. Vafai, and J.B. Stock Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits EMBO J 19 2000 5682 5691
49. J. Wu, T. Tolstykh, J. Lee, K. Boyd, J.B. Stock, and J.R. Broach Carboxyl methylation of the phosphoprotein phosphatase 2A catalytic subunit promotes its functional association with regulatory subunits in vivo EMBO J 19 2000 5672 5681
50. J. Chen, B.L. Martin, and D.L. Brautigan Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation Science 257 1992 1261 1264
51. C.X. Gong, T.J. Singh, I. Grundke-Iqbal, and K. Iqbal Phosphoprotein phosphatase activities in Alzheimer disease brain J Neurochem 61 1993 921 927 (Pubitemid 23241228)
52. E. Sontag, C. Hladik, L. Montgomery, A. Luangpirom, I. Mudrak, and E. Ogris Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis J Neuropathol Exp Neurol 63 2004 1080 1091 (Pubitemid 39372592)
53. E. Sontag, A. Luangpirom, C. Hladik, I. Mudrak, E. Ogris, and S. Speciale Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology J Neuropathol Exp Neurol 63 2004 287 301 (Pubitemid 38429026)
54. P. Rudrabhatla, and H.C. Pant Role of protein phosphatase 2A in Alzheimer's disease Curr Alzheimer Res 2001 [Epub ahead of print]
55. V. Vogelsberg-Ragaglia, T. Schuck, J.Q. Trojanowski, and V.M. Lee PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus Exp Neurol 168 2001 402 412 (Pubitemid 32289776)
56. H. Tanimukai, I. Grundke-Iqbal, and K. Iqbal Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease Am J Pathol 166 2005 1761 1771 (Pubitemid 40734399)
57. A. Gharbi-Ayachi, J.C. Labbe, A. Burgess, S. Vigneron, J.M. Strub, and E. Brioudes The substrate of Greatwall kinase, Arpp 19, controls mitosis by inhibiting protein phosphatase 2A Science 330 2010 1673 1677
58. S. Mochida, S.L. Maslen, M. Skehel, and T. Hunt Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis Science 330 2010 1670 1673
59. S.H. Kim, A.C. Nairn, N. Cairns, and G. Lubec Decreased levels of ARPP-19 and PKA in brains of Down syndrome and Alzheimer's disease J Neural Transm 61 2001 263 272 Suppl (Pubitemid 38085088)
60. X.W. Zhou, J.A. Gustafsson, H. Tanila, C. Bjorkdahl, R. Liu, and B. Winblad Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A Neurobiol Dis 31 2008 386 394
61. J.C. Bryant, R.S. Westphal, and B.E. Wadzinski Methylated C-terminal leucine residue of PP2A catalytic subunit is important for binding of regulatory Balpha subunit Biochem J 339 Pt. 2 1999 241 246 (Pubitemid 29209953)
62. C.M. Chen, Y.T. Hou, J.Y. Liu, Y.R. Wu, C.H. Lin, and H.C. Fung PPP2R2B CAG repeat length in the Han Chinese in Taiwan: association analyses in neurological and psychiatric disorders and potential functional implications Am J Med Genet B Neuropsychiatr Genet 150B 2009 124 129
63. R. Kimura, T. Morihara, T. Kudo, K. Kamino, and M. Takeda Association between CAG repeat length in the PPP2R2B gene and Alzheimer disease in the Japanese population Neurosci Lett 487 2011 354 357
64. F. Liu, Z. Liang, and C.X. Gong Hyperphosphorylation of tau and protein phosphatases in Alzheimer disease Panminerva Med 48 2006 97 108 (Pubitemid 44671265)
65. K. Iqbal, A.C. Alonso, S. Chen, M.O. Chohan, E. El-Akkad, and C.X. Gong Tau pathology in Alzheimer disease and other tauopathies Biochim Biophys Acta 1739 2005 198 210 (Pubitemid 40018538)
66. Y. Xu, Y. Chen, P. Zhang, P.D. Jeffrey, and Y. Shi Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation Mol Cell 31 2008 873 885
67. A. Bulbarelli, E. Lonati, E. Cazzaniga, M. Gregori, and M. Masserini Pin1 affects Tau phosphorylation in response to Abeta oligomers Mol Cell Neurosci 42 2009 75 80
68. I. Landrieu, C. Smet-Nocca, L. Amniai, J.V. Louis, J.M. Wieruszeski, and J. Goris Molecular implication of PP2A and Pin1 in the Alzheimer's disease specific hyperphosphorylation of tau PLoS One 6 2011 e21521
69. E. Sontag, V. Nunbhakdi-Craig, J.M. Sontag, R. Diaz-Arrastia, E. Ogris, and S. Dayal Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation J Neurosci 27 2007 2751 2759 (Pubitemid 46438990)
70. A. Colombo, A. Bastone, C. Ploia, A. Sclip, M. Salmona, and G. Forloni JNK regulates APP cleavage and degradation in a model of Alzheimer's disease Neurobiol Dis 33 2009 518 525
71. J. Shin, S.B. Yu, U.Y. Yu, S.A. Jo, and J.H. Ahn Swedish mutation within amyloid precursor protein modulates global gene expression towards the pathogenesis of Alzheimer's disease BMB Rep 43 2010 704 709
72. R. Liu, X.W. Zhou, H. Tanila, C. Bjorkdahl, J.Z. Wang, and Z.Z. Guan Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology J Cell Mol Med 12 2008 241 257 (Pubitemid 351430466)
73. S. Klumpp, and J. Krieglstein Serine/threonine protein phosphatases in apoptosis Curr Opin Pharmacol 2 2002 458 462 (Pubitemid 34830979)
74. P.P. Ruvolo, X. Deng, T. Ito, B.K. Carr, and W.S. May Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A J Biol Chem 274 1999 20296 20300
75. C. Culmsee, and S. Landshamer Molecular insights into mechanisms of the cell death program: role in the progression of neurodegenerative disorders Curr Alzheimer Res 3 2006 269 283 (Pubitemid 44351472)
76. T.P. Shanley, N. Vasi, A. Denenberg, and H.R. Wong The serine/threonine phosphatase, PP2A: endogenous regulator of inflammatory cell signaling J Immunol 166 2001 966 972 (Pubitemid 32060252)
77. E.E. Tuppo, and H.R. Arias The role of inflammation in Alzheimer's disease Int J Biochem Cell Biol 37 2005 289 305 (Pubitemid 39330191)
78. Y.J. Lee, S.B. Han, S.Y. Nam, K.W. Oh, and J.T. Hong Inflammation and Alzheimer's disease Arch Pharm Res 33 2010 1539 1556
79. G.P. Lim, F. Yang, T. Chu, P. Chen, W. Beech, and B. Teter Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease J Neurosci 20 2000 5709 5714 (Pubitemid 30636898)
80. G.M. Cole, T. Morihara, G.P. Lim, F. Yang, A. Begum, and S.A. Frautschy NSAID and antioxidant prevention of Alzheimer's disease: lessons from in vitro and animal models Ann N Y Acad Sci 1035 2004 68 84 (Pubitemid 40362327)
81. J.C. Breitner The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease Annu Rev Med 47 1996 401 411 (Pubitemid 26138900)
82. C.A. Szekely, J.C. Breitner, and P.P. Zandi Prevention of Alzheimer's disease Int Rev Psychiatry 19 2007 693 706 (Pubitemid 351185554)
83. J. Woods, M. Snape, and M.A. Smith The cell cycle hypothesis of Alzheimer's disease: suggestions for drug development Biochim Biophys Acta 1772 2007 503 508 (Pubitemid 46400390)
84. Z. Nagy, M.M. Esiri, and A.D. Smith Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions Acta Neuropathol 93 1997 294 300 (Pubitemid 27104426)
85. K.H. Park, J.L. Hallows, P. Chakrabarty, P. Davies, and I. Vincent Conditional neuronal simian virus 40 T antigen expression induces Alzheimer-like tau and amyloid pathology in mice J Neurosci 27 2007 2969 2978 (Pubitemid 46438995)
86. C. Wurzenberger, and D.W. Gerlich Phosphatases: providing safe passage through mitotic exit Nat Rev Mol Cell Biol 12 2011 469 482
87. P. Turowski, A. Fernandez, B. Favre, N.J. Lamb, and B.A. Hemmings Differential methylation and altered conformation of cytoplasmic and nuclear forms of protein phosphatase 2A during cell cycle progression J Cell Biol 129 1995 397 410
88. J. Gotz, A. Probst, E. Ehler, B. Hemmings, and W. Kues Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha Proc Natl Acad Sci USA 95 1998 12370 12375 (Pubitemid 28483772)
89. S. Kins, A. Crameri, D.R. Evans, B.A. Hemmings, R.M. Nitsch, and J. Gotz Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice J Biol Chem 276 2001 38193 38200
90. N. Deters, L.M. Ittner, and J. Gotz Substrate-specific reduction of PP2A activity exaggerates tau pathology Biochem Biophys Res Commun 379 2009 400 405
91. T. Arendt, M. Holzer, R. Fruth, M.K. Bruckner, and U. Gartner Paired helical filament-like phosphorylation of tau, deposition of beta/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A Neuroscience 69 1995 691 698
92. T. Arendt, M. Holzer, R. Fruth, M.K. Bruckner, and U. Gartner Phosphorylation of tau, Abeta-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A Neurobiol Aging 19 1998 3 13 (Pubitemid 28167790)
93. X. Wang, J. Blanchard, E. Kohlbrenner, N. Clement, R.M. Linden, and A. Radu The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment FASEB J 24 2010 4420 4432
94. A. Schild, K. Schmidt, Y.A. Lim, Y. Ke, L.M. Ittner, and B.A. Hemmings Altered levels of PP2A regulatory B/PR55 isoforms indicate role in neuronal differentiation Int J Dev Neurosci 24 2006 437 443 (Pubitemid 44584604)
95. J.V. Louis, E. Martens, P. Borghgraef, C. Lambrecht, W. Sents, and S. Longin Mice lacking phosphatase PP2A subunit PR61/B'delta (Ppp 2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3beta Proc Natl Acad Sci USA 108 2011 6957 6962
96. E. Planel, K.E. Richter, C.E. Nolan, J.E. Finley, L. Liu, and Y. Wen Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia J Neurosci 27 2007 3090 3097 (Pubitemid 46474135)
97. R.A. Whittington, L. Virag, F. Marcouiller, M.A. Papon, N.B. El Khoury, and C. Julien Propofol directly increases tau phosphorylation PLoS One 6 2011 e16648
98. J. Aramburu, A. Rao, and C.B. Klee Calcineurin: from structure to function Curr Top Cell Regul 36 2000 237 295
99. R.M. Mulkey, S. Endo, S. Shenolikar, and R.C. Malenka Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression Nature 369 1994 486 488
100. D.G. Winder, and J.D. Sweatt Roles of serine/threonine phosphatases in hippocampal synaptic plasticity Nat Rev Neurosci 2 2001 461 474 (Pubitemid 33676581)
101. I.M. Mansuy Calcineurin in memory and bidirectional plasticity Biochem Biophys Res Commun 311 2003 1195 1208 (Pubitemid 37393442)
102. M.A. Cousin, and P.J. Robinson The dephosphins: dephosphorylation by calcineurin triggers synaptic vesicle endocytosis Trends Neurosci 24 2001 659 665 (Pubitemid 33152773)
103. J.L. Sanderson, and M.L. Dell'Acqua AKAP signaling complexes in regulation of excitatory synaptic plasticity Neuroscientist 17 2011 321 336
104. A.M. Oliveira, and H. Bading Calcium signaling in cognition and aging-dependent cognitive decline Biofactors 37 2011 168 174
105. A. Agbas, A. Zaidi, and E.K. Michaelis Decreased activity and increased aggregation of brain calcineurin during aging Brain Res 1059 2005 59 71 (Pubitemid 41457327)
106. M.L. Billingsley, C. Ellis, R.L. Kincaid, J. Martin, M.L. Schmidt, and V.M. Lee Calcineurin immunoreactivity in Alzheimer's disease Exp Neurol 126 1994 178 184 (Pubitemid 24182039)
107. C.J. Ladner, J. Czech, J. Maurice, S.A. Lorens, and J.M. Lee Reduction of calcineurin enzymatic activity in Alzheimer's disease: correlation with neuropathologic changes J Neuropathol Exp Neurol 55 1996 924 931 (Pubitemid 26287009)
108. Q. Lian, C.J. Ladner, D. Magnuson, and J.M. Lee Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex Exp Neurol 167 2001 158 165 (Pubitemid 32066418)
109. F. Celsi, M. Svedberg, C. Unger, C.W. Cotman, M.T. Carri, and O.P. Ottersen Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress Neurobiol Dis 26 2007 342 352 (Pubitemid 46561337)
110. F. Liu, I. Grundke-Iqbal, K. Iqbal, Y. Oda, K. Tomizawa, and C.X. Gong Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain J Biol Chem 280 2005 37755 37762 (Pubitemid 41642385)
111. W. Qian, X. Yin, W. Hu, J. Shi, J. Gu, and I. Grundke-Iqbal Activation of protein phosphatase 2B and hyperphosphorylation of Tau in Alzheimer's disease J Alzheimers Dis 23 2011 617 627
112. A.H. Mohmmad, I. Baig, H. Levine III, R.P. Guttmann, and C.M. Norris Proteolysis of calcineurin is increased in human hippocampus during mild cognitive impairment and is stimulated by oligomeric Abeta in primary cell culture Aging Cell 10 2011 103 113
113. M. D'Amelio, V. Cavallucci, S. Middei, C. Marchetti, S. Pacioni, and A. Ferri Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease Nat Neurosci 14 2011 69 76
114. G. Ermak, T.E. Morgan, and K.J. Davies Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer's disease J Biol Chem 276 2001 38787 38794
115. G. Ermak, and K.J. Davies Gene expression in Alzheimer's disease Drugs Today (Barc) 38 2002 509 516 (Pubitemid 34875497)
116. C.N. Cook, M.J. Hejna, D.J. Magnuson, and J.M. Lee Expression of calcipressin1, an inhibitor of the phosphatase calcineurin, is altered with aging and Alzheimer's disease J Alzheimers Dis 8 2005 63 73 (Pubitemid 41267325)
117. C. Cruchaga, J.S. Kauwe, K. Mayo, N. Spiegel, S. Bertelsen, and P. Nowotny SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease PLoS Genet 6 2010 e1001101
118. M.J. Chiocco, X. Zhu, D. Walther, O. Pletnikova, J.C. Troncoso, and G.R. Uhl Fine mapping of calcineurin (PPP3CA) gene reveals novel alternative splicing patterns, association of 5'UTR trinucleotide repeat with addiction vulnerability, and differential isoform expression in Alzheimer's disease Subst Use Misuse 45 2010 1809 1826
119. C.M. Norris, I. Kadish, E.M. Blalock, K.C. Chen, V. Thibault, and N.M. Porter Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models J Neurosci 25 2005 4649 4658 (Pubitemid 40629156)
120. F. Desdouits, J.D. Buxbaum, J. Desdouits-Magnen, A.C. Nairn, and P. Greengard Amyloid beta peptide formation in cell-free preparations. Regulation by protein kinase C, calmodulin, and calcineurin J Biol Chem 271 1996 24670 24674 (Pubitemid 26333210)
121. Y. Kim, Y.I. Lee, M. Seo, S.Y. Kim, J.E. Lee, and H.D. Youn Calcineurin dephosphorylates glycogen synthase kinase-3 beta at serine-9 in neuroblast-derived cells J Neurochem 111 2009 344 354
122. R. Katzman, R. Terry, R. DeTeresa, T. Brown, P. Davies, and P. Fuld Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques Ann Neurol 23 1988 138 144 (Pubitemid 18081451)
123. S.T. DeKosky, and S.W. Scheff Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity Ann Neurol 27 1990 457 464 (Pubitemid 20149963)
124. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. DeTeresa, and R. Hill Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Ann Neurol 30 1991 572 580
125. A.Y. Hsia, E. Masliah, L. McConlogue, G.Q. Yu, G. Tatsuno, and K. Hu Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models Proc Natl Acad Sci USA 96 1999 3228 3233 (Pubitemid 29148873)
126. J. Larson, G. Lynch, D. Games, and P. Seubert Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice Brain Res 840 1999 23 35 (Pubitemid 29434821)
127. F. Kamenetz, T. Tomita, H. Hsieh, G. Seabrook, D. Borchelt, and T. Iwatsubo APP processing and synaptic function Neuron 37 2003 925 937 (Pubitemid 36398299)
128. L. Mucke, E. Masliah, G.Q. Yu, M. Mallory, E.M. Rockenstein, and G. Tatsuno High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation J Neurosci 20 2000 4050 4058 (Pubitemid 30365675)
129. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, and M.S. Wolfe Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539 (Pubitemid 34288854)
130. J.P. Cleary, D.M. Walsh, J.J. Hofmeister, G.M. Shankar, M.A. Kuskowski, and D.J. Selkoe Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function Nat Neurosci 8 2005 79 84 (Pubitemid 41236735)
131. J.J. Palop, J. Chin, E.D. Roberson, J. Wang, M.T. Thwin, and N. Bien-Ly Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease Neuron 55 2007 697 711 (Pubitemid 47321079)
132. P.N. Lacor, M.C. Buniel, P.W. Furlow, A.S. Clemente, P.T. Velasco, and M. Wood Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease J Neurosci 27 2007 796 807 (Pubitemid 46174498)
133. G.M. Shankar, B.L. Bloodgood, M. Townsend, D.M. Walsh, D.J. Selkoe, and B.L. Sabatini Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway J Neurosci 27 2007 2866 2875 (Pubitemid 46438992)
134. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791 (Pubitemid 35231524)
135. D.J. Selkoe Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior Behav Brain Res 192 2008 106 113
136. E.M. Snyder, Y. Nong, C.G. Almeida, S. Paul, T. Moran, and E.Y. Choi Regulation of NMDA receptor trafficking by amyloid-beta Nat Neurosci 8 2005 1051 1058 (Pubitemid 41061516)
137. C.G. Almeida, D. Tampellini, R.H. Takahashi, P. Greengard, M.T. Lin, and E.M. Snyder Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses Neurobiol Dis 20 2005 187 198 (Pubitemid 41476246)
138. H. Hsieh, J. Boehm, C. Sato, T. Iwatsubo, T. Tomita, and S. Sisodia AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss Neuron 52 2006 831 843 (Pubitemid 44828454)
139. S. Li, S. Hong, N.E. Shepardson, D.M. Walsh, G.M. Shankar, and D. Selkoe Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake Neuron 62 2009 788 801
140. J. Lauren, D.A. Gimbel, H.B. Nygaard, J.W. Gilbert, and S.M. Strittmatter Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers Nature 457 2009 1128 1132
141. D.A. Gimbel, H.B. Nygaard, E.E. Coffey, E.C. Gunther, J. Lauren, and Z.A. Gimbel Memory impairment in transgenic Alzheimer mice requires cellular prion protein J Neurosci 30 2010 6367 6374
142. Q.S. Chen, W.Z. Wei, T. Shimahara, and C.W. Xie Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus Neurobiol Learn Mem 77 2002 354 371 (Pubitemid 34971647)
143. M.P. Mattson, and S.L. Chan Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits J Mol Neurosci 17 2001 205 224 (Pubitemid 33063525)
144. S. Camandola, and M.P. Mattson Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease Biochim Biophys Acta 1813 2011 965 973
145. W.Q. Zhao, F. Santini, R. Breese, D. Ross, X.D. Zhang, and D.J. Stone Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5- methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption J Biol Chem 285 2010 7619 7632
146. K.T. Dineley, D. Hogan, W.R. Zhang, and G. Taglialatela Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice Neurobiol Learn Mem 88 2007 217 224 (Pubitemid 47223751)
147. G. Taglialatela, D. Hogan, W.R. Zhang, and K.T. Dineley Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition Behav Brain Res 200 2009 95 99
148. K.T. Dineley, R. Kayed, V. Neugebauer, Y. Fu, W. Zhang, and L.C. Reese Amyloid-beta oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice J Neurosci Res 88 2010 2923 2932
149. H.Y. Wu, E. Hudry, T. Hashimoto, K. Kuchibhotla, A. Rozkalne, and Z. Fan Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation J Neurosci 30 2010 2636 2649
150. K.V. Kuchibhotla, S.T. Goldman, C.R. Lattarulo, H.Y. Wu, B.T. Hyman, and B.J. Bacskai Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks Neuron 59 2008 214 225 (Pubitemid 352033686)
151. R.A. Robinson, M.B. Lange, R. Sultana, V. Galvan, J. Fombonne, and O. Gorostiza Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-beta peptide of amyloid precursor protein(Xi) Neuroscience 177 2011 207 222
152. M.D. Ehlers Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting Neuron 28 2000 511 525
153. G.L. Snyder, S. Galdi, A.A. Fienberg, P. Allen, A.C. Nairn, and P. Greengard Regulation of AMPA receptor dephosphorylation by glutamate receptor agonists Neuropharmacology 45 2003 703 713 (Pubitemid 38340356)
154. S.W. Flavell, C.W. Cowan, T.K. Kim, P.L. Greer, Y. Lin, and S. Paradis Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number Science 311 2006 1008 1012 (Pubitemid 43271729)
155. H.M. Abdul, M.A. Sama, J.L. Furman, D.M. Mathis, T.L. Beckett, and A.M. Weidner Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling J Neurosci 29 2009 12957 12969
156. P. Agostinho, J.P. Lopes, Z. Velez, and C.R. Oliveira Overactivation of calcineurin induced by amyloid-beta and prion proteins Neurochem Int 52 2008 1226 1233
157. L.C. Reese, W. Zhang, K.T. Dineley, R. Kayed, and G. Taglialatela Selective induction of calcineurin activity and signaling by oligomeric amyloid beta Aging Cell 7 2008 824 835 (Pubitemid 352749437)
158. I.M. Mansuy, and S. Shenolikar Protein serine/threonine phosphatases in neuronal plasticity and disorders of learning and memory Trends Neurosci 29 2006 679 686 (Pubitemid 44794536)
159. W. Morishita, J.H. Connor, H. Xia, E.M. Quinlan, S. Shenolikar, and R.C. Malenka Regulation of synaptic strength by protein phosphatase 1 Neuron 32 2001 1133 1148 (Pubitemid 34075402)
160. D. Genoux, U. Haditsch, M. Knobloch, A. Michalon, D. Storm, and I.M. Mansuy Protein phosphatase 1 is a molecular constraint on learning and memory Nature 418 2002 970 975 (Pubitemid 34976031)
161. M. Bollen Combinatorial control of protein phosphatase-1 Trends Biochem Sci 26 2001 426 431 (Pubitemid 32607484)
162. L.C. Hsieh-Wilson, F. Benfenati, G.L. Snyder, P.B. Allen, A.C. Nairn, and P. Greengard Phosphorylation of spinophilin modulates its interaction with actin filaments J Biol Chem 278 2003 1186 1194 (Pubitemid 36790800)
163. D. Sarrouilhe, T.A. di, T. Metaye, and V. Ladeveze Spinophilin: from partners to functions Biochimie 88 2006 1099 1113
164. M.J. Ragusa, B. Dancheck, D.A. Critton, A.C. Nairn, R. Page, and W. Peti Spinophilin directs protein phosphatase 1 specificity by blocking substrate binding sites Nat Struct Mol Biol 17 2010 459 464
165. M. Hagiwara, A. Alberts, P. Brindle, J. Meinkoth, J. Feramisco, and T. Deng Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB Cell 70 1992 105 113
166. K. Koshibu, J. Graff, M. Beullens, F.D. Heitz, D. Berchtold, and H. Russig Protein phosphatase 1 regulates the histone code for long-term memory J Neurosci 29 2009 13079 13089
167. G. Canettieri, I. Morantte, E. Guzman, H. Asahara, S. Herzig, and S.D. Anderson Attenuation of a phosphorylation-dependent activator by an HDAC-PP1 complex Nat Struct Biol 10 2003 175 181 (Pubitemid 36297986)
168. N.E. Lapointe, G. Morfini, G. Pigino, I.N. Gaisina, A.P. Kozikowski, and L.I. Binder The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity J Neurosci Res 87 2009 440 451
169. N.M. Kanaan, G.A. Morfini, N.E. Lapointe, G.F. Pigino, K.R. Patterson, and Y. Song Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases J Neurosci 31 2011 9858 9868
170. M. Knobloch, M. Farinelli, U. Konietzko, R.M. Nitsch, and I.M. Mansuy Abeta oligomer-mediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanisms J Neurosci 27 2007 7648 7653 (Pubitemid 47093800)
171. R.M. Mulkey, C.E. Herron, and R.C. Malenka An essential role for protein phosphatases in hippocampal long-term depression Science 261 1993 1051 1055 (Pubitemid 23300866)
172. A.P. Vintem, A.G. Henriques, E. da Cruz, O.A. Silva, E. da Cruz, and E.F. Silva PP1 inhibition by Abeta peptide as a potential pathological mechanism in Alzheimer's disease Neurotoxicol Teratol 31 2009 85 88
173. T. O'Connor, K.R. Sadleir, E. Maus, R.A. Velliquette, J. Zhao, and S.L. Cole Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis Neuron 60 2008 988 1009
174. L.B. Yang, K. Lindholm, R. Yan, M. Citron, W. Xia, and X.L. Yang Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease Nat Med 9 2003 3 4 (Pubitemid 36098241)
175. J. Zhao, Y. Fu, M. Yasvoina, P. Shao, B. Hitt, and T. O'Connor Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis J Neurosci 27 2007 3639 3649 (Pubitemid 46557686)
176. M.H. Brush, D.C. Weiser, and S. Shenolikar Growth arrest and DNA damage-inducible protein GADD34 targets protein phosphatase 1 alpha to the endoplasmic reticulum and promotes dephosphorylation of the alpha subunit of eukaryotic translation initiation factor 2 Mol Cell Biol 23 2003 1292 1303 (Pubitemid 36177038)
177. S.J. Marciniak, and D. Ron Endoplasmic reticulum stress signaling in disease Physiol Rev 86 2006 1133 1149 (Pubitemid 44521649)
178. M. Boyce, K.F. Bryant, C. Jousse, K. Long, H.P. Harding, and D. Scheuner A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress Science 307 2005 935 939 (Pubitemid 40229232)
179. T.D. Hinds Jr., and E.R. Sanchez Protein phosphatase 5 Int J Biochem Cell Biol 40 2008 2358 2362
180. E. Sanchez-Ortiz, B.K. Hahm, D.L. Armstrong, and S. Rossie Protein phosphatase 5 protects neurons against amyloid-beta toxicity J Neurochem 111 2009 391 402
181. P.H. Reddy, and M.F. Beal Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease Trends Mol Med 14 2008 45 53
182. P.J. Lombroso, J.R. Naegele, E. Sharma, and M. Lerner A protein tyrosine phosphatase expressed within dopaminoceptive neurons of the basal ganglia and related structures J Neurosci 13 1993 3064 3074 (Pubitemid 23199231)
183. L.M. Boulanger, P.J. Lombroso, A. Raghunathan, M.J. During, P. Wahle, and J.R. Naegele Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase J Neurosci 15 1995 1532 1544
184. S.P. Braithwaite, S. Paul, A.C. Nairn, and P.J. Lombroso Synaptic plasticity: one STEP at a time Trends Neurosci 29 2006 452 458 (Pubitemid 44118442)
185. T. Oyama, S. Goto, T. Nishi, K. Sato, K. Yamada, and M. Yoshikawa Immunocytochemical localization of the striatal enriched protein tyrosine phosphatase in the rat striatum: a light and electron microscopic study with a complementary DNA-generated polyclonal antibody Neuroscience 69 1995 869 880
186. S.M. Goebel-Goody, M. Baum, C. Paspalas, N.C. Carty, S. Fernandez, and P. Kurup Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders Pharmacol Rev 2011 [Epub ahead of print]
187. R. Pulido, A. Zuniga, and A. Ullrich PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif EMBO J 17 1998 7337 7350 (Pubitemid 29002702)
188. S. Paul, A.C. Nairn, P. Wang, and P.J. Lombroso NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling Nat Neurosci 6 2003 34 42 (Pubitemid 36026330)
189. T.H. Nguyen, J. Liu, and P.J. Lombroso Striatal enriched phosphatase 61 dephosphorylates Fyn at phosphotyrosine 420 J Biol Chem 277 2002 24274 24279 (Pubitemid 34951945)
190. D.V. Venkitaramani, P.J. Moura, M.R. Picciotto, and P.J. Lombroso Striatal-enriched protein tyrosine phosphatase (STEP) knockout mice have enhanced hippocampal memory Eur J Neurosci 33 2011 2288 2298
191. K.A. Pelkey, R. Askalan, S. Paul, L.V. Kalia, T.H. Nguyen, and G.M. Pitcher Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation Neuron 34 2002 127 138 (Pubitemid 34270704)
192. Y. Zhang, D.V. Venkitaramani, C.M. Gladding, Y. Zhang, P. Kurup, and E. Molnar The tyrosine phosphatase STEP mediates AMPA receptor endocytosis after metabotropic glutamate receptor stimulation J Neurosci 28 2008 10561 10566
193. S.P. Braithwaite, M. Adkisson, J. Leung, A. Nava, B. Masterson, and R. Urfer Regulation of NMDA receptor trafficking and function by striatal-enriched tyrosine phosphatase (STEP) Eur J Neurosci 23 2006 2847 2856 (Pubitemid 43882863)
194. Y. Zhang, P. Kurup, J. Xu, N. Carty, S.M. Fernandez, and H.B. Nygaard Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model Proc Natl Acad Sci USA 107 2010 19014 19019
195. J.J. Munoz, C. Tarrega, C. Blanco-Aparicio, and R. Pulido Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents Biochem J 372 2003 193 201 (Pubitemid 36609621)
196. S. Paul, G.L. Snyder, H. Yokakura, M.R. Picciotto, A.C. Nairn, and P.J. Lombroso The Dopamine/D1 receptor mediates the phosphorylation and inactivation of the protein tyrosine phosphatase STEP via a PKA-dependent pathway J Neurosci 20 2000 5630 5638 (Pubitemid 30636889)
197. E. Valjent, V. Pascoli, P. Svenningsson, S. Paul, H. Enslen, and J.C. Corvol From The Cover: regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum Proc Natl Acad Sci USA 102 2005 491 496 (Pubitemid 40116794)
198. Y. Hu, Y. Zhang, D.V. Venkitaramani, and P.J. Lombroso Translation of striatal-enriched protein tyrosine phosphatase (STEP) after beta1-adrenergic receptor stimulation J Neurochem 103 2007 531 541 (Pubitemid 47498011)
199. T.H. Nguyen, S. Paul, Y. Xu, J.W. Gurd, and P.J. Lombroso Calcium-dependent cleavage of striatal enriched tyrosine phosphatase (STEP) J Neurochem 73 1999 1995 2001 (Pubitemid 29491813)
200. J. Xu, P. Kurup, Y. Zhang, S.M. Goebel-Goody, P.H. Wu, and A.H. Hawasli Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP J Neurosci 29 2009 9330 9343
201. P. Kurup, Y. Zhang, J. Xu, D.V. Venkitaramani, V. Haroutunian, and P. Greengard Abeta-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61 J Neurosci 30 2010 5948 5957
202. Y. Zhang, P. Kurup, J. Xu, G.M. Anderson, P. Greengard, and A.C. Nairn Reduced levels of the tyrosine phosphatase STEP block beta amyloid-mediated GluA1/GluA2 receptor internalization J Neurochem 119 2011 664 672
203. K.W. Roche, S. Standley, J. McCallum, L.C. Dune, M.D. Ehlers, and R.J. Wenthold Molecular determinants of NMDA receptor internalization Nat Neurosci 4 2001 794 802 (Pubitemid 32702511)
204. D.V. Venkitaramani, S. Paul, Y. Zhang, P. Kurup, L. Ding, and L. Tressler Knockout of striatal enriched protein tyrosine phosphatase in mice results in increased ERK1/2 phosphorylation Synapse 63 2009 69 81
205. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, and R. Kayed Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction Neuron 39 2003 409 421 (Pubitemid 36937044)
206. T. Hayashi, and R.L. Huganir Tyrosine phosphorylation and regulation of the AMPA receptor by SRC family tyrosine kinases J Neurosci 24 2004 6152 6160 (Pubitemid 38891106)
207. R. Scholz, S. Berberich, L. Rathgeber, A. Kolleker, G. Kohr, and H.C. Kornau AMPA receptor signaling through BRAG2 and Arf6 critical for long-term synaptic depression Neuron 66 2010 768 780
208. S.K. Shirazi, and J.G. Wood The protein tyrosine kinase, fyn, in Alzheimer's disease pathology Neuroreport 4 1993 435 437 (Pubitemid 23116742)
209. G. Lee, R. Thangavel, V.M. Sharma, J.M. Litersky, K. Bhaskar, and S.M. Fang Phosphorylation of tau by fyn: implications for Alzheimer's disease J Neurosci 24 2004 2304 2312 (Pubitemid 38314562)
210. P. Derkinderen, T.M. Scales, D.P. Hanger, K.Y. Leung, H.L. Byers, and M.A. Ward Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase J Neurosci 25 2005 6584 6593 (Pubitemid 40995290)
211. J. Chin, J.J. Palop, G.Q. Yu, N. Kojima, E. Masliah, and L. Mucke Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice J Neurosci 24 2004 4692 4697 (Pubitemid 38656624)
212. J. Chin, J.J. Palop, J. Puolivali, C. Massaro, N. Bien-Ly, and H. Gerstein Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease J Neurosci 25 2005 9694 9703 (Pubitemid 41510910)
213. L.M. Ittner, Y.D. Ke, F. Delerue, M. Bi, A. Gladbach, and E.J. van Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models Cell 142 2010 387 397
214. E.D. Roberson, B. Halabisky, J.W. Yoo, J. Yao, J. Chin, and F. Yan Amyloid-beta/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease J Neurosci 31 2011 700 711
215. F.M. de Vrij, D.F. Fischer, F.W. van Leeuwen, and E.M. Hol Protein quality control in Alzheimer's disease by the ubiquitin proteasome system Prog Neurobiol 74 2004 249 270 (Pubitemid 39586719)
216. S.C. Upadhya, and A.N. Hegde Role of the ubiquitin proteasome system in Alzheimer's disease BMC Biochem 8 Suppl. 1 2007 S12
217. S. Oddo The ubiquitin-proteasome system in Alzheimer's disease J Cell Mol Med 12 2008 363 373 (Pubitemid 351555121)
218. H. Mori, J. Kondo, and Y. Ihara Ubiquitin is a component of paired helical filaments in Alzheimer's disease Science 235 1987 1641 1644 (Pubitemid 17050146)
219. Y.A. Lam, C.M. Pickart, A. Alban, M. Landon, C. Jamieson, and R. Ramage Inhibition of the ubiquitin-proteasome system in Alzheimer's disease Proc Natl Acad Sci USA 97 2000 9902 9906
220. D.C. David, R. Layfield, L. Serpell, Y. Narain, M. Goedert, and M.G. Spillantini Proteasomal degradation of tau protein J Neurochem 83 2002 176 185
221. H. Qing, W. Zhou, M.A. Christensen, X. Sun, Y. Tong, and W. Song Degradation of BACE by the ubiquitin-proteasome pathway FASEB J 18 2004 1571 1573 (Pubitemid 39561636)
222. G. He, H. Qing, F. Cai, C. Kwok, H. Xu, and G. Yu Ubiquitin-proteasome pathway mediates degradation of APH-1 J Neurochem 99 2006 1403 1412 (Pubitemid 44730094)
223. G. He, H. Qing, Y. Tong, F. Cai, S. Ishiura, and W. Song Degradation of nicastrin involves both proteasome and lysosome J Neurochem 101 2007 982 992 (Pubitemid 46683872)
224. B. Gong, Z. Cao, P. Zheng, O.V. Vitolo, S. Liu, and A. Staniszewski Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory Cell 126 2006 775 788 (Pubitemid 44233627)
225. B.P. Tseng, K.N. Green, J.L. Chan, M. Blurton-Jones, and F.M. LaFerla Abeta inhibits the proteasome and enhances amyloid and tau accumulation Neurobiol Aging 29 2008 1607 1618
226. S. Oh, H.S. Hong, E. Hwang, H.J. Sim, W. Lee, and S.J. Shin Amyloid peptide attenuates the proteasome activity in neuronal cells Mech Ageing Dev 126 2005 1292 1299 (Pubitemid 41572246)
227. D.L. Smith, J. Pozueta, B. Gong, O. Arancio, and M. Shelanski Reversal of long-term dendritic spine alterations in Alzheimer disease models Proc Natl Acad Sci USA 106 2009 16877 16882
228. Y. Zhu, H. Hou, K. Rezai-Zadeh, B. Giunta, A. Ruscin, and C. Gemma CD45 deficiency drives amyloid-beta peptide oligomers and neuronal loss in Alzheimer's disease mice J Neurosci 31 2011 1355 1365
229. N. Mody, A. Agouni, G.D. McIlroy, B. Platt, and M. Delibegovic Susceptibility to diet-induced obesity and glucose intolerance in the APP (SWE)/PSEN1 (A246E) mouse model of Alzheimer's disease is associated with increased brain levels of protein tyrosine phosphatase 1B (PTP1B) and retinol-binding protein 4 (RBP4), and basal phosphorylation of S6 ribosomal protein Diabetologia 54 2011 2143 2151
230. Z. Nagy, M.M. Esiri, A.M. Cato, and A.D. Smith Cell cycle markers in the hippocampus in Alzheimer's disease Acta Neuropathol 94 1997 6 15 (Pubitemid 27289096)
231. X.L. Ding, J. Husseman, A. Tomashevski, D. Nochlin, L.W. Jin, and I. Vincent The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease Am J Pathol 157 2000 1983 1990
232. I. Vincent, B. Bu, K. Hudson, J. Husseman, D. Nochlin, and L. Jin Constitutive Cdc25B tyrosine phosphatase activity in adult brain neurons with M phase-type alterations in Alzheimer's disease Neuroscience 105 2001 639 650 (Pubitemid 32769828)
233. S.B. De, R. Vassar, and T. Golde The secretases: enzymes with therapeutic potential in Alzheimer disease Nat Rev Neurol 6 2010 99 107
234. J. Cummings What can be inferred from the interruption of the semagacestat trial for treatment of Alzheimer's disease? Biol Psychiatry 68 2010 876 878
235. A. Extance Alzheimer's failure raises questions about disease-modifying strategies Nat Rev Drug Discov 9 2010 749 751
236. M. Voronkov, S.P. Braithwaite, and J.B. Stock Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease Future Med Chem 3 2011 821 833
237. N.M. Corcoran, D. Martin, B. Hutter-Paier, M. Windisch, T. Nguyen, and L. Nheu Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model J Clin Neurosci 17 2010 1025 1033
238. E.J. van, Y.D. Ke, X. Liu, F. Delerue, J.J. Kril, and J. Gotz Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models Proc Natl Acad Sci USA 107 2010 13888 13893
239. M.O. Chohan, S. Khatoon, I.G. Iqbal, and K. Iqbal Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine FEBS Lett 580 2006 3973 3979 (Pubitemid 43946883)
240. E. Kickstein, S. Krauss, P. Thornhill, D. Rutschow, R. Zeller, and J. Sharkey Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling Proc Natl Acad Sci USA 107 2010 21830 21835
241. K.W. Lee, W. Chen, E. Junn, J.Y. Im, H. Grosso, and P.K. Sonsalla Enhanced phosphatase activity attenuates alpha-Synucleinopathy in a mouse model J Neurosci 31 2011 6963 6971
242. S. Liu, L.F. Zeng, L. Wu, X. Yu, T. Xue, and A.M. Gunawan Targeting inactive enzyme conformation: aryl diketoacid derivatives as a new class of PTP1B inhibitors J Am Chem Soc 130 2008 17075 17084
243. S. Wu, M. Bottini, R.C. Rickert, T. Mustelin, and L. Tautz In silico screening for PTPN22 inhibitors: active hits from an inactive phosphatase conformation ChemMedChem 4 2009 440 444
244. X. Zhang, Y. He, S. Liu, Z. Yu, Z.X. Jiang, and Z. Yang Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) J Med Chem 53 2010 2482 2493
245. A.J. Barr, E. Ugochukwu, W.H. Lee, O.N. King, P. Filippakopoulos, and I. Alfano Large-scale structural analysis of the classical human protein tyrosine phosphatome Cell 136 2009 352 363
246. E. Sergienko, J. Xu, W.e. Liu, R. Dahl, D.A. Critton, and Y. Su A specific inhibitor of hematopoietic protein tyrosine phosphatase augments ERK and p38 activation in vivo ACS Chem Biol 2011 [In press]
247. J.F. Borel, C. Feurer, H.U. Gubler, and H. Stahelin Biological effects of cyclosporin A: a new antilymphocytic agent Agents Actions 6 1976 468 475
248. R.Y. Calne, K. Rolles, D.J. White, S. Thiru, D.B. Evans, and P. McMaster Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers Lancet 2 1979 1033 1036 (Pubitemid 10213970)
249. M. Naesens, D.R. Kuypers, and M. Sarwal Calcineurin inhibitor nephrotoxicity Clin J Am Soc Nephrol 4 2009 481 508
250. W.O. Bechstein Neurotoxicity of calcineurin inhibitors: impact and clinical management Transpl Int 13 2000 313 326
251. M. Sieber, and R. Baumgrass Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506? Cell Commun Signal 7 2009 25